25085-99-8Relevant articles and documents
HERBICIDE COMPOSITION COMPRISING CLOMAZONE AND USE THEREOF
-
Page/Page column 17-19, (2018/03/09)
A composition comprising a water-immiscible material or high volatile material encapsulated within a microcapsule is provided, the microcapsules having a shell comprising a polyurea cross-linked by epoxy resin polymer. The method for preparing the same, and the use of the same in the control of unwanted plant growth are also provided.
An in situ prepared photo-luminescent transparent biocompatible hyperbranched epoxy/carbon dot nanocomposite
De, Bibekananda,Kumar, Manishekhar,Mandal, Biman B.,Karak, Niranjan
, p. 74692 - 74704 (2015/09/21)
A photo-luminescent transparent biocompatible hyperbranched epoxy/carbon dot nanocomposite was prepared by incorporation of carbon dots during formation of hyperbranched epoxy resin. The prepared nanocomposite was characterized by FTIR, NMR and TEM analyses. The poly(amido-amine) cured nanocomposite exhibited high tensile strength (62.5 MPa), high elongation at break (45%), good thermal stability (291 °C), high transparency and excellent wavelength dependent photoluminescence behavior along with biocompatibility with skin cells. The performance of this nanocomposite was also compared with the pristine hyperbranched epoxy as well as hyperbranched epoxy/carbon dot nanocomposite obtained through an ex situ solution technique. The study revealed that the in situ prepared nanocomposite possessed superior mechanical, optical and biocompatible properties compared to pristine epoxy as well as the ex situ prepared nanocomposite. Thus, the study will significantly contribute to the field of high performance transparent fluorescent polymeric materials used in optoelectronics. Good viability, spreading and proliferation of skin fibroblasts and keratinocyte cells on the nanocomposite suggest it is also a highly potential material for bio-sealant application.
BISPHENOL COMPOUNDS AND METHODS FOR THEIR USE
-
Page/Page column 90-91, (2012/10/18)
Compounds having a structure of Formula I: wherein G, a, Q, L2, R1, R2, R3, R4, R5 and R6 are as defined herein are provided. Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provided.